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Premedication with 
midazolam is equally 
effective via the sublingual 
and intravenous route of 
administration
ABSTRACT
Background. The aim of this study was to investigate the clinical efficacy and potential side effects of sublingual midazolam, 
used for premedication, in comparison with intravenous midazolam. The second aim was to explore cost-effectiveness of 
sublingual midazolam administration.
Methods. A prospective, randomized, controlled, single-blinded trial was conducted at the Clinical Hospital Centre Osijek, 
Croatia, during the period 1st of May till 31st of October, 2012. We enrolled 140 patients (American Society of Anesthesio-
logists (ASA) physical status I-II, age≥18 years) scheduled for some kind of elective surgical procedure. Exclusion criteria 
were ASA III or higher, psychiatric disorders, allergy to midazolam and use of psychotropic drugs. Patients were randomi-
zed into one of two groups. One group received 2.5 mg of midazolam intravenously and the other group received 1/4 of a 
midazolam tablet (approximately 3.75 mg) sublingually. Sedation was clinically evaluated using the Ramsey sedation scale 
at 0, 10, 20 and 30 minutes after drug administration. We also noted side effects and degree of amnesia.
Results. Ten minutes after administration of premedication, a significantly higher number of patients in the intravenous group 
had a Ramsey score of 2 (p=0.000). Ten and twenty minutes after drug administration, most of the patients in the sublingual 
group had a Ramsey score 1-2, and after 30 minutes most of them had a Ramsey score 2-3, which is comparable with the 
intravenous (p=0.642) group. 
Conclusion. Sublingual application of midazolam has an equivalent sedative effect as intravenous midazolam 20 minutes 
after administration but is associated with a bitter taste  and weaker amnestic effect.
TOMISLAV RUŽMAN (  )
Department of Anesthesiology 
Resuscitation and Intensive care unit
University Hospital Osijek 
Josipa Huttlera 4. 31000 Osijek, Croatia
Phone: +385 (0)31 511 502
Fax: +385(0)31 512 205
E-mail: tomislav1707@yahoo.com
TOMISLAV RUŽMAN • MARINA KREŠIĆ • 
DUBRAVKA IVIĆ • DANIJELA GULAM
Department of Anesthesiology, Resuscitation 
and Intensive care unit
Clinical Hospital Centre Osijek 
Medical Faculty, University Josip Juraj Stross-
mayer Osijek
Osijek, Croatia
NATAŠA RUŽMAN • 
JELENA BURAZIN
Institute of Public Health for Osijek-Baranya 
County, Osijek, Croatia
TOMISLAV RUŽMAN • MARINA KREŠIĆ • DUBRAVKA IVIĆ • 
DANIJELA GULAM • NATAŠA RUŽMAN • JELENA BURAZIN
ORIGINAL
   SIGNA VITAE 2014; 9(2): 32 - 36
Key words: premedication, midazo-
lam, sublingual, intravenous
Introduction
Most patients are anxious, afraid or 
agitated while waiting for surgery. (1,2) 
This can lead to significant stress and 
adversely influence anesthetic inducti-
on, and often leads to a poorer recovery 
after surgery. (3-5) Anxiety can also 
decrease patient’s satisfaction with the 
perioperative experience. (6) The most 
important drugs for premedication are 
benzodiazepines, opioids, alpha-2 
adrenoreceptor agonists, melatonin, 
dexmedetomidine or other drugs which 
have an anxiolytic, analgesic or sedati-
ve effect. (7,8)     
Sedative premedication can be admi-
nistered orally, intramuscularly, intrave-
nously, rectally, sublingually or nasally. 
Oral or sublingual application does not 
hurt, but it may have a slow onset or the 
medication may be spit out. Drug taste 
is the main determinant for the success 
of their administration. Intramuscular 
medications may hurt and may result 
in a sterile abscess. Intravenous medi-
cations may be painful during injection 
or at the start of the infusion. Rectal 
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medications, which are mostly used 
for children, may sometimes make the 
children feel uncomfortable and they 
may cause defecation, and occasio-
nally burns. Nasal medications can be 
irritating, although their absorption is 
rapid. The choice of best premedicati-
on route and drug must be adapted to 
each patient. (9)
The ideal agent should have a rapid 
onset, a predictable duration of action 
and enable rapid recovery. Midazo-
lam, a sedative from the benzodiaze-
pines group, has most of the above 
attributes and is most frequently used 
for premedication before anesthesia. 
(7,10-13) Its advantage is good bioa-
vailability regardless of route of appli-
cation, such as intravenous, intramus-
cular or transmucosal (oral, intranasal, 
rectal or sublingual). 
The sublingual route of administration 
for some medications is a good choi-
ce because of good pharmacokinetic 
properties and simple application wit-
hout pain. One advantage of this route 
of application is avoidance of the first 
pass effect and an increase in bioa-
vailability of the drug and thus more 
predictable pharmacological effects. 
(14,15)  Sublingual administration of 
the parenteral soluble form of midazo-
lam was investigated in many previous 
studies, especially in children and just 
a few studies have described sublin-
gual application of oral midazolam 
tablets. (16)
The aim of this study was to investiga-
te clinical efficacy and potential side 
effects of sublingual application in 
comparison with intravenous applica-
tion of midazolam used for premedi-
cation. 
Methods
Ethical approval for this study (Ethical 
Committee N° 25-1:3160-6/2012) was 
provided by the Ethical Committee of 
Clinical Hospital Centre Osijek, Osijek, 
Croatia (Chairperson Anto Rašić) on 
18th April, 2012.
It was a prospective, randomized, con-
trolled, single-blinded investigation. 
The studied population included 140 
patients undergoing elective orthope-
dics, abdominal, urologic, maxillofacial 
or thoracic surgery, who were due to 
receive midazolam as a premedication. 
The main inclusion criteria included 
ASA (American Society of Anesthesio-
logists) physical status class I or II and 
older than 18 years of age. Exclusion 
criteria were an ASA physical status of 
class III or higher, patients with psychi-
atric disorders, and those taking antip-
sychotics, chronic use of benzodiazepi-
nes, and allergy to midazolam.
The patients were randomized into one 
of two groups. One group (intra venous 
group) received 2.5 mg of Midazolam 
intravenously (Roche Dormicum, 15 
mg/3mL ampulla) and the other group 
(sublingual group) of patients received 
1/4 of a midazolam oral tablet (approxi-
mately 3.75 mg; Roche Dormicum, 15 
mg tablets) sublingually (s.l.). The dose 
of ¼ midazolam tablet was clinically 
estimated as the amount needed for 
adequate premedication, and was rela-
tively comparable with 2.5 mg of mida-
zolam administered intravenously (i.v.), 
which is the mostly frequently used 
dose for premedication for the average 
patient.
 In the sublingual group, the tablet was 
placed under the tongue and patients 
were instructed not to swallow the 
tablet. Assessments were carried out 
before and after midazolam admini-
stration by an anesthesiologist who 
did not know about the administration 
route. Anxiety and sedation were evalu-
ated using the Ramsey sedation scale 
(table 1). A baseline sedation score 
was noted by a researcher prior to drug 
administration. Then the patients were 
observed at an interval of 10, 20 and 30 
minutes after drug administration in the 
surgical holding areas. At the end of the 
study, the patients in both groups were 
asked about side effects and amnesia. 
Also, the investigator noted demograp-
hic data and data about surgery and 
type of anesthesia.
All data were entered in a database, and 
analyses were done with SPSS 17.0 sta-
tistical programme. Most of the data are 
reported as mean ± SD or percentage 
(%). Differences between groups were 
analyzed using Chi-square or unpaired 
Student’s t-tests. P was considered sta-
tistically significant if p < 0.05.
Results
This analysis identified epidemiological 
and clinical characteristics of two diffe-
rent applications of midazolam preme-
dication at the Department of Anesthe-
siology, Resuscitation and Intensive 
Care Unit (ICU), University Hospital 
Osijek in Croatia. The study included 
140 patients who underwent some kind 
of surgery, with six patients excluded 
due to chronic use of antipsychotics, 
benzodiazepines or other psychotropic 
drugs. Epidemiological data for each 
group were described in table 2.  There 
were no statistically significant differen-
ces between the groups for most of the 
tested demographic variables except 
height (p=0.034). The studied popu-
lation consisted of 83.57 % (117/140) 
orthopedics patients and 14.28 % 
(20/140) abdominal surgery patients. 
The rest included one urological, one 
thoracic and one maxillofacial patient. 
Also, 60 % (84/140) of operations were 
conducted under spinal anesthesia, 
20.7 % (29/140) under general ane-
sthesia and 19.3 % (27/140) using ultra-
sound guided regional nerve blocks, 
and there was no statistical difference 
Table 1. Ramsey sedation scale.
Score Response to stimulation
0 Awake, oriented
1 Anxious or restless or both
2 Cooperative, orientated and tranquil
3 Responding to command only
4 Brisk response to light glabellar tap or loud auditory stimulus
5 Sluggish response to light glabellar tap or loud auditory stimulus
6 No response to stimulus
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between these groups. One half of the 
patients (70/140) received midazolam 
sublingually and the other half recei-
ved premedication intravenously. The 
sublingual tablets dissolved within 3-5 
minutes. The characteristics of sedati-
on are described in table 3. None of the 
patients in the intravenous group had 
side effects after premedication, and 24 
(34.3%) patients in the sublingual group 
complained about the bitter taste of the 
tablet (p=0.000). Partial or complete 
anterograde amnesia after surgery was 
experienced by 17.9 % (25/140) of the 
patients, most of them (19/140) in the 
intravenous group (p=0.016).
Discussion
Most patients are anxious or afraid 
before anesthesia and surgery and they 
require some kind of premedication. 
We conducted this study to show the 
benefits of sublingual administration of 
midazolam tablets for premedication. 
Like most studies, we found that only 25 
% of patients seemed relatively calm, 
and more than 72 % of surgical patients 
had fear or anxiety before interventi-
ons. Therefore, premedication before 
anesthesia is necessary to alleviate 
anxiety, to facilitate smooth induction 
of anesthesia and to inhibit autonomic 
Table 2. Epidemiological characteristics of study groups.
Sublingual group
n(%), mean ± SD
Intravenous group
n(%), mean ± SD
p value









WEIGHT (kg) 82,37±17,31 83,84±21,00 0,652
HEIGHT (cm) 173,58±8,99 166,24±27,18 0,034*









ASA physical status, American Society of Anesthesiologist physical status; BMI, body mass index.
Independent Student t-test was used for obtaining statistical difference between groups
*p< 0.05
Table 3.  Clinically assessed Ramsey scores at 0, 10, 20, 30 minutes after 
midazolam premedication.









1   (0,7)
15 (10,7)
53 (37,9)





















0    (0)
44  (31,4)
26  (18,6)
0    (0)
1    (0,7)
38  (27,1)
27  (19,3)













1   (0,7)
1    (0,7)
32  (22,9)
31  (22,1)
5    (3,6)
0,642
RS0, Baseline Ramsey score; RS10, Ramsey score after 10 minutes; RS20, Ramsey score 
after 20 minutes; RS30, Ramsey score after 30 minutes.
Chi-square test was used for obtaining a statistical difference between groups
*p< 0.05
 35www.signavitae.com
reflexes without prolonging the reco-
very period. There are numerous drugs 
for this, but in our daily practice mida-
zolam is used most often because it 
has been found to fulfill many of the 
above criteria. (7) The anesthesiolo-
gist must choose the best route for 
premedication which must be simple, 
painless, and pleasant for the patient. 
This can be achieved by transmucosal 
application across oral, nasal or rectal 
mucosa. (17-21) The sublingual route 
has an advantage because of mucosal 
absorption directly into the systemic 
circulation, with no first pass through 
the liver, due to the rich blood supply 
of oral mucosa, it is easy to administer, 
has rapid onset of action, a reliable, 
predictable effect and the drug is not 
destroyed by gastrointestinal enzymes. 
There are many studies which compare 
effects of different routes for midazolam 
application. (9,15-17,20,22,23) Studies 
which compared sublingual with oro-
gastric route showed that midazolam 
plasma levels are greater after sublin-
gual application in comparison with 
orogastric  route. A study by Fujii et 
al. had proven better bioavailability by 
sublingual route in comparison with 
oral route for midazolam tablets. (22) 
There is one study which compared 
intravenous and sublingual midazolam 
application. In this study Odou’s et al. 
in France showed no significant diffe-
rences between pharmacokinetic para-
meter values after intravenous (0.5 mg 
solution) and sublingual administration 
(0.5 mg tablet) in six rabbits. (24)
In our study with 140 patients, clinical 
comparison was made between the 
sublingual and intravenous application 
of midazolam used as premedicati-
on before some surgical interventions. 
Each group was studied for sedati-
on scores after midazolam application 
and for possible unwanted effects and 
amnesia after surgery. There was no 
significant difference in most demo-
graphic variables except in height 
between these two groups. After cli-
nically assessing sedation levels, we 
found that sublingual application of 
midazolam had a sedative effect which 
is comparable with intravenous. We did 
not find a significant difference in base-
line sedation scores before premedica-
tion between the groups. Although ten 
minutes after midazolam application 
both groups had satisfactory Ramsey 
scores (RS 1-2), significantly more pati-
ents from the intravenous group had RS 
score 2 (p=0.000) due to direct appli-
cation of the drug into blood. However, 
twenty minutes after premedication, 
most of the patients in the sublingual 
group had satisfactory sedation levels 
which ensured calm and quality induc-
tion of anesthesia. Only a few patients 
in the intravenous group had RS score 
4 at the same time. Because of a slower 
increase in blood concentration in the 
sublingual group, RS score 4 was noted 
only 30 minutes after premedication. 
Thirty minutes after midazolam applica-
tion the patients had reasonably deeper 
scores (RS 2-4), but without statisti-
cal differences between the groups 
(p=0.642). Also, none of the patients 
had an unacceptably deep level of 
sedation, higher then Ramsey score 4. 
Likewise, recent studies showed a rapid 
and good sedation effect after sublin-
gual midazolam application due to very 
fast absorption across oral mucosa. 
(9,15,17,20,23) Gupta et al. found, in a 
population of 60 children, that the desi-
rable level of sedation and separation 
before surgery was achieved earlier in 
the case of sublingual midazolam than 
the oral route. (23)
Just a small percentage of the patients 
in both groups (17.9 %) had complete 
or partial anterograde amnesia after 
surgery. We can explain this with the 
small doses of midazolam used for 
premedication. These doses provide 
satisfactory anxiolysis and good seda-
tion but are most probably insufficient 
for amnesia development.  About one 
third of the patients in the sublingual 
group complained about a bitter taste 
after tablet dissolving, and none of the 
patients in the intravenous group had 
unwanted side effects. We observed 
that female patients complained more 
often about tablet taste.
After using midazolam tablets sublin-
gually, we think that the only disadvan-
tages are the taste and a large tablet 
dose which requires dividing the tablet 
into small parts. In the future, the phar-
maceutical industry should consider 
developing special midazolam tablets 
for sublingual premedication with the 
appropriate dose and good taste. 
In our study, we did not investigate con-
sumption of anesthetics and analgesi-
cs during anesthesia, nor postanesthe-
sia recovery variables, but we clinically 
observed that there was no difference 
between these groups regarding reco-
very time after surgery. Also, we did not 
measure plasma levels of midazolam 
because of technical limitations and 
large costs.
Finally, our intention in this study was 
also to show the cost-effectiveness of 
sublingual application of midazolam 
tablets. One tablet of 15 mg of mida-
zolam costs about 0.30 Euro, and one 
ampoule of 15 mg of midazolam costs 
about 1.6 Euros. There is also the cost 
of needles and syringes for intravenous 
application. Therefore, sublingual appli-
cation is cheaper than intravenous. This 
may not seem significant, but in hospi-
tals that have a large number of surgical 
patients savings might be significant.
In conclusion, sublingual application 
of an oral midazolam tablet reaches 
equivalent sedative effects compared 
with intravenous midazolam 20 minutes 
after administration but is associated 
with a bitter taste and less amnesic 
effect. Given the slower onset, diffi-
culty for tablet dissolving (unreliable 
absorption), the unpleasant bitter taste, 
the possibility of administrative proce-
ss induced anxiety and less amnesic 
effect, we cannot say sublingual admi-
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